FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157443457> ?p ?o ?g. }

• W2157443457 abstract "Thymoquinone (TQ) is a compound extracted from Black Caraway seeds of Nigella Sativa and is active against various cancers. Cisplatin (CDDP) is the most active chemotherapeutic agent in Lung Cancer. Here we report activity of TQ against non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) cell lines alone and in combination with Cisplatin (CDDP). For proliferation MTT assay, cell viability trypan blue assay and for apoptosis Annexin-V FITC assay were used in NCI-H460 and NCI-H146 cell lines. Inhibition of invasion by TQ was assessed using Matrigel assay and its affect on release of various cytokines was determined using RayBio Human Cytokine detection kit. Mouse xenograft model using NCI-H460 was used to determine in vivo activity of TQ and CDDP. Inhibition of LPS induced NF-κB expression by TQ was determined using transgenic mice expressing a luciferase reporter. TQ was able to inhibit cell proliferation, reduce cell viability and induce apoptosis. TQ at 100 μM and CDDP at 5 μM inhibited cell proliferation by nearly 90% and the combination showed synergism. TQ was able to induced apoptosis in both NCI-H460 and NCI-H146 cell lines. TQ also appears to affect the extracellular environment inhibiting invasion and reducing the production of two cytokines ENA-78 and Gro-alpha which are involved in neo-angiogenesis. Using a mouse xenograft model we were able to demonstrate that combination of TQ and CDDP was well tolerated and significantly reduced tumor volume and tumor weight without additional toxicity to the mice. In the combination arms (TQ5 mg/kg/Cis 2.5 mg/kg) tumor volume was reduced by 59% and (TQ20 mg/kg/Cis 2.5 mg/kg) by 79% as compared to control which is consistent with in vitro data. TQ down regulated NF-κB expression which may explain its various cellular activities and this activity may prove useful in overcoming CDDP resistance from over expression of NF-κB. Thus TQ and CDDP appear to be an active therapeutic combination in lung cancer." @default.
• W2157443457 created "2016-06-24" @default.
• W2157443457 creator A5008660028 @default.
• W2157443457 creator A5044314141 @default.
• W2157443457 creator A5049451215 @default.
• W2157443457 creator A5062197967 @default.
• W2157443457 creator A5069383851 @default.
• W2157443457 creator A5085040543 @default.
• W2157443457 date "2010-07-01" @default.
• W2157443457 modified "2023-10-18" @default.
• W2157443457 title "Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo" @default.
• W2157443457 cites W1621475458 @default.
• W2157443457 cites W1865435071 @default.
• W2157443457 cites W1964925281 @default.
• W2157443457 cites W1974693247 @default.
• W2157443457 cites W1975776530 @default.
• W2157443457 cites W1982294158 @default.
• W2157443457 cites W2000394421 @default.
• W2157443457 cites W2007456673 @default.
• W2157443457 cites W2010239869 @default.
• W2157443457 cites W2020788984 @default.
• W2157443457 cites W2021252415 @default.
• W2157443457 cites W2033234613 @default.
• W2157443457 cites W2037139573 @default.
• W2157443457 cites W2043103956 @default.
• W2157443457 cites W2051810280 @default.
• W2157443457 cites W2051899483 @default.
• W2157443457 cites W2094419555 @default.
• W2157443457 cites W2100837269 @default.
• W2157443457 cites W2101108802 @default.
• W2157443457 cites W2104504726 @default.
• W2157443457 cites W2107353013 @default.
• W2157443457 cites W2138297714 @default.
• W2157443457 cites W2143372911 @default.
• W2157443457 cites W2145835533 @default.
• W2157443457 cites W2155290347 @default.
• W2157443457 cites W2566863750 @default.
• W2157443457 doi "https://doi.org/10.1186/1756-9966-29-87" @default.
• W2157443457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2909169" @default.
• W2157443457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20594324" @default.
• W2157443457 hasPublicationYear "2010" @default.
• W2157443457 type Work @default.
• W2157443457 sameAs 2157443457 @default.
• W2157443457 citedByCount "195" @default.
• W2157443457 countsByYear W21574434572012 @default.
• W2157443457 countsByYear W21574434572013 @default.
• W2157443457 countsByYear W21574434572014 @default.
• W2157443457 countsByYear W21574434572015 @default.
• W2157443457 countsByYear W21574434572016 @default.
• W2157443457 countsByYear W21574434572017 @default.
• W2157443457 countsByYear W21574434572018 @default.
• W2157443457 countsByYear W21574434572019 @default.
• W2157443457 countsByYear W21574434572020 @default.
• W2157443457 countsByYear W21574434572021 @default.
• W2157443457 countsByYear W21574434572022 @default.
• W2157443457 countsByYear W21574434572023 @default.
• W2157443457 crossrefType "journal-article" @default.
• W2157443457 hasAuthorship W2157443457A5008660028 @default.
• W2157443457 hasAuthorship W2157443457A5044314141 @default.
• W2157443457 hasAuthorship W2157443457A5049451215 @default.
• W2157443457 hasAuthorship W2157443457A5062197967 @default.
• W2157443457 hasAuthorship W2157443457A5069383851 @default.
• W2157443457 hasAuthorship W2157443457A5085040543 @default.
• W2157443457 hasBestOaLocation W21574434571 @default.
• W2157443457 hasConcept C126322002 @default.
• W2157443457 hasConcept C150903083 @default.
• W2157443457 hasConcept C185592680 @default.
• W2157443457 hasConcept C190283241 @default.
• W2157443457 hasConcept C207001950 @default.
• W2157443457 hasConcept C2776694085 @default.
• W2157443457 hasConcept C2778004101 @default.
• W2157443457 hasConcept C2778239845 @default.
• W2157443457 hasConcept C2778608917 @default.
• W2157443457 hasConcept C2779034068 @default.
• W2157443457 hasConcept C2780394083 @default.
• W2157443457 hasConcept C2780783641 @default.
• W2157443457 hasConcept C502942594 @default.
• W2157443457 hasConcept C53227056 @default.
• W2157443457 hasConcept C54355233 @default.
• W2157443457 hasConcept C55493867 @default.
• W2157443457 hasConcept C62112901 @default.
• W2157443457 hasConcept C71924100 @default.
• W2157443457 hasConcept C81885089 @default.
• W2157443457 hasConcept C86803240 @default.
• W2157443457 hasConcept C88634738 @default.
• W2157443457 hasConcept C98274493 @default.
• W2157443457 hasConceptScore W2157443457C126322002 @default.
• W2157443457 hasConceptScore W2157443457C150903083 @default.
• W2157443457 hasConceptScore W2157443457C185592680 @default.
• W2157443457 hasConceptScore W2157443457C190283241 @default.
• W2157443457 hasConceptScore W2157443457C207001950 @default.
• W2157443457 hasConceptScore W2157443457C2776694085 @default.
• W2157443457 hasConceptScore W2157443457C2778004101 @default.
• W2157443457 hasConceptScore W2157443457C2778239845 @default.
• W2157443457 hasConceptScore W2157443457C2778608917 @default.
• W2157443457 hasConceptScore W2157443457C2779034068 @default.
• W2157443457 hasConceptScore W2157443457C2780394083 @default.
• W2157443457 hasConceptScore W2157443457C2780783641 @default.
• W2157443457 hasConceptScore W2157443457C502942594 @default.
• W2157443457 hasConceptScore W2157443457C53227056 @default.

• next